Applied Aerospace & Defense
AADX
11.26
-0.54
-4.58%
Applied Aerospace & Defense
US · AADX
#2808 by market cap
Listed 2026
11.26
-0.54
-4.58%
Live - 5344 symbols - heartbeat 252s ago
· 2026-10-08 09:18
Pre-market
11.23
-0.27%
After-hours
11.26
0.00%
Overnight
11.25
-0.09%
- Market cap
- 1.94B
- P/E (TTM)i
- -11.15
- P/Bi
- 2.34
- EPSi
- -0.10
- Div yieldi
- 0.00%
- 52W posi
- 0%
Reader sentiment
Are you bullish or bearish on AADX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.33, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 2 years
Latest year +51.17% YoY
Margins
- Gross margin
- 27.22%
- Operating margin
- 9.42%
- Net margin
- -8.11%
Key ratios & quality
- Enterprise valuei
- 2.56B
- Altman Z-Scorei
- 2.33
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2024 | 2025 |
|---|---|---|
| Revenue | 399.79M | 604.34M |
| Gross profit | 98.08M | 164.52M |
| Selling & admin expenses | 41.75M | 65.23M |
| Research & development | -- | -- |
| Operating profit | 32.87M | 56.96M |
| Pretax profit | -30.84M | -46.88M |
| Tax | 3.93M | 2.14M |
| Net profit | -34.77M | -49.02M |
| Basic EPS | 0 | 0 |
| Diluted EPS | -0.20 | -0.29 |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Revenue | 111.02M | 113.50M | 151.98M | 167.32M |
| Gross profit | 30.88M | 32.03M | 36.54M | 37.19M |
| Selling & admin expenses | 12.37M | 11.58M | 82.75M | 123.32M |
| Research & development | -- | -- | -- | -- |
| Operating profit | 11.98M | 13.91M | -57.04M | -96.23M |
| Pretax profit | -4.74M | -3.02M | -79.98M | -122.48M |
| Tax | 2.57M | 1.65M | -1.18M | 31.49M |
| Net profit | -7.31M | -4.68M | -78.80M | -153.97M |
| Basic EPS | 0 | 0 | 0 | -1 |
| Diluted EPS | -0.04 | -0.03 | -0.46 | -1.04 |
Balance sheet
| Line item | 2024 | 2025 |
|---|---|---|
| Total current assets | 244.97M | 291.57M |
| Cash & ST investments | 27.47M | 15.48M |
| Inventory | 50.49M | 57.38M |
| Total assets | 949.79M | 999.30M |
| Total current liabilities | 113.54M | 94.48M |
| Short-term debt | 23.89M | 11.69M |
| Long-term debt | 554.95M | 626.98M |
| Total liabilities | 783,947,000.00 | 839,837,000.00 |
| Total equity | 165.85M | 159.46M |
| Retained earnings | -46.01M | -63.04M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Total current assets | -- | -- | 334.74M | 355.06M |
| Cash & ST investments | -- | -- | 15.92M | 18.11M |
| Inventory | -- | -- | 64.69M | 60.96M |
| Total assets | -- | -- | 1.48B | 1.50B |
| Total current liabilities | -- | -- | 160.26M | 141.50M |
| Short-term debt | -- | -- | 62.43M | 7.14M |
| Long-term debt | -- | -- | 948.72M | 395.17M |
| Total liabilities | -- | -- | 1,250,131,000.00 | 672,338,000.00 |
| Total equity | -- | -- | 233.79M | 827.88M |
| Retained earnings | -- | -- | -78.17M | -232.14M |
Cash flow
| Line item | 2024 | 2025 |
|---|---|---|
| Operating cash flow | 4.65M | -28.94M |
| Depreciation & amortization | 35.22M | 39.42M |
| Free cash flow | -10.23M | -46.37M |
| Dividends paid | -80.00M | 0 |
| Stock buybacks / issuance | -- | -- |
| Ending cash balance | 27.47M | 15.48M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Operating cash flow | -6.91M | -9.76M | -72.03M | -10.06M |
| Depreciation & amortization | 9.72M | 9.66M | 12.11M | 15.13M |
| Free cash flow | -11.82M | -8.86M | -79.17M | -24.56M |
| Dividends paid | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 18.70M | 635.64M |
| Ending cash balance | 8.51M | 7.60M | 15.92M | 18.11M |
Returns & efficiency
| Line item | 2024 | 2025 |
|---|---|---|
| ROE %i | -20.96 | -30.14 |
| ROA %i | -3.66 | -5.03 |
| ROIC %i | 1.63 | 3.52 |
| 5-year avg ROE %i | -- | -- |
| EBIT margin %i | 8.22 | 9.42 |
| FCF / sales %i | -- | -- |
| Current ratioi | 2.16 | 3.09 |
| Quick ratioi | 1.67 | 2.41 |
| Debt / assetsi | 64.23 | 66.95 |
| LT debt / equityi | 353.42 | 412.24 |
| Interest coveragei | 0.52 | 0.55 |
| Revenue CAGR (3Y) %i | -- | -- |
| Net income CAGR (3Y) %i | -- | -- |
| FCF CAGR (3Y) %i | -- | -- |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| ROE %i | -- | -- | -51.54 | -24.90 |
| ROA %i | -- | -- | -8.12 | -13.74 |
| ROIC %i | -- | -- | -0.93 | -10.93 |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -1.87 | -9.98 |
| FCF / sales %i | -- | -- | -- | -- |
| Current ratioi | -- | -- | 2.09 | 2.51 |
| Quick ratioi | -- | -- | 1.63 | 2.02 |
| Debt / assetsi | -- | -- | 70.15 | 28.77 |
| LT debt / equityi | -- | -- | 418.57 | 51.26 |
| Interest coveragei | -- | -- | -0.11 | -0.60 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
Quote time 2026-10-08 09:18:36 · For reference only, not investment advice and not tailored to your situation.